Ogivri 150 mg

OGIVRI 150 MG is a powder for solution used in intravenous therapy. It contains trastuzumab, a biosimilar medication for targeted treatment in specific conditions.

OGIVRI 150 MG is primarily used in the treatment of certain types of cancer. It works by targeting specific proteins to help slow or stop the growth of cancer cells. This medication is often prescribed as part of a broader treatment plan, including chemotherapy or other therapies. Patients should consult their healthcare provider to understand what is OGIVRI 150 MG used for in their specific case.

Common effects of OGIVRI 150 MG may include fatigue, nausea, and injection site reactions. Some patients might experience more severe side effects, such as fever or difficulty breathing. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

OGIVRI 150 MG should be handled with care, following the instructions provided by a healthcare professional. It is crucial to store the medication properly and use it as directed. Patients with a history of heart problems or allergies should inform their healthcare provider before starting treatment.

OGIVRI 150 MG may interact with other medications, including those that affect the immune system or heart function. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the treatment.